rxstat › Shortages › Telmisartan Hydrochlorothiazide

Telmisartan Hydrochlorothiazide shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Telmisartan Hydrochlorothiazide products are in shortage in Canada (3 of 23 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
3 / 23
In shortage since
May 22, 2017
Reports on file
97
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-TELMISARTAN HCTZ
80MG 12.5MG · TABLET · TEVA CANADA LIMITED
DIN 02330288 · since Apr 8, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-TELMISARTAN HCTZ
12.5MG 80MG · TABLET · TEVA CANADA LIMITED
DIN 02330288 · since Feb 4, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-TELMISARTAN HCTZ
80.0MG 25.0MG · TABLET · TEVA CANADA LIMITED
DIN 02379252 · since Jul 16, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-TELMISARTAN HCTZ
80.0MG 25.0MG · TABLET · TEVA CANADA LIMITED
DIN 02379252 · since Nov 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-TELMISARTAN/HCTZ
25MG 80MG · TABLET · APOTEX INC
DIN 02420031 · since May 22, 2017, no end estimate · Disruption of the manufacture of the drug.
Resolved
SANDOZ TELMISARTAN HCT
80MG 12.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02393557 · ended Feb 23, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP TELMISARTAN-HCT
25MG 80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02389959 · ended Nov 11, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP TELMISARTAN-HCT
25MG 80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02389959 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP TELMISARTAN-HCT
12.5MG 80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02389940 · ended Nov 11, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP TELMISARTAN-HCT
12.5MG 80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02389940 · ended Nov 19, 2025 · Disruption of the manufacture of the drug.
Resolved
TELMISARTAN HCTZ
25MG 80MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02390310 · ended Sep 16, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-TELMISARTAN HCTZ
80MG 25MG · TABLET · AURO PHARMA INC
DIN 02456397 · ended May 15, 2025 · Demand increase for the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Telmisartan Hydrochlorothiazide is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Telmisartan Hydrochlorothiazide is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).

Recent changes

Common questions

When will Telmisartan Hydrochlorothiazide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Telmisartan Hydrochlorothiazide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, combinations)

Partial shortageAmlodipine Telmisartan2 of 6 reported products affectedPartial shortageHydrochlorothiazide Candesartan Cilexetil4 of 21 reported products affected · est. return Aug 31, 2026Partial shortageHydrochlorothiazide Irbesartan13 of 35 reported products affected · est. return Dec 4, 2026Partial shortageHydrochlorothiazide Losartan3 of 35 reported products affected · est. return Jul 7, 2026Partial shortageHydrochlorothiazide Valsartan5 of 27 reported products affected · est. return Jul 31, 2026Partial shortageOlmesartan Medoxomil Hydrochlorothiazide6 of 24 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.